GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SEEGENE Inc (XKRX:096530) » Definitions » Total Liabilities

SEEGENE (XKRX:096530) Total Liabilities : ₩225,966 Mil (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is SEEGENE Total Liabilities?

SEEGENE's Total Liabilities for the quarter that ended in Mar. 2024 was ₩225,966 Mil.

SEEGENE's quarterly Total Liabilities increased from Sep. 2023 (₩213,119.62 Mil) to Dec. 2023 (₩221,052.94 Mil) and increased from Dec. 2023 (₩221,052.94 Mil) to Mar. 2024 (₩225,966.42 Mil).

SEEGENE's annual Total Liabilities declined from Dec. 2021 (₩406,122.21 Mil) to Dec. 2022 (₩240,498.58 Mil) and declined from Dec. 2022 (₩240,498.58 Mil) to Dec. 2023 (₩221,052.94 Mil).


SEEGENE Total Liabilities Historical Data

The historical data trend for SEEGENE's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SEEGENE Total Liabilities Chart

SEEGENE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 42,889.89 448,168.70 406,122.21 240,498.58 221,052.94

SEEGENE Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 245,301.50 216,285.89 213,119.62 221,052.94 225,966.42

SEEGENE Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

SEEGENE's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=162153.146+(47204.289+10330.82
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+1364.683)
=221,053

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=1251451.914-1030398.976
=221,053

SEEGENE's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=160155.857+(53650.113+10717.794
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+1442.656)
=225,966

Total Liabilities=Total Assets (Q: Mar. 2024 )-Total Equity (Q: Mar. 2024 )
=1251142.943-1025176.523
=225,966

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SEEGENE Total Liabilities Related Terms

Thank you for viewing the detailed overview of SEEGENE's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


SEEGENE (XKRX:096530) Business Description

Traded in Other Exchanges
N/A
Address
Taewon Building 65-5 Bangyi-Dong, Songpa-gu, Seoul, KOR, 138-050
SEEGENE Inc is engaged in the healthcare sector. The Korean firm specializes in developing upgraded technology for accurate diagnosis of various diseases. Its products include pathogen inspection solutions such as respiratory, gastrointestinal, tuberculosis and meningitis pathogens.

SEEGENE (XKRX:096530) Headlines

No Headlines